After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Immunovant Inc is $3.49B. A total of 1.77 million shares were traded on the day, compared to an average of 894.90K shares.
In the most recent transaction, Roivant Sciences Ltd. bought 16,845,010 shares of IMVT for 20.00 per share on Jan 13 ’25. After the transaction, the Director now owns 96,650,341 company shares. In a previous transaction on Jan 08 ’25, Barnett Eva Renee sold 4,105 shares at 24.10 per share. IMVT shares that Chief Financial Officer owns now total 327,064.
Among the insiders who sold shares, Salzmann Peter disposed of 5,105 shares on Jan 08 ’25 at a per-share price of $24.10. This resulted in the Chief Executive Officer holding 972,992 shares of IMVT after the transaction. In another insider transaction, Pande Atul sold 7,750 shares at $28.54 per share on Dec 02 ’24. Company shares held by the Director now total 86,663.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, IMVT has a high of $42.44 and a low of $22.41.
As of this writing, IMVT has an earnings estimate of -$0.75 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.56 per share and a lower estimate of -$0.83.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IMVT’s latest balance sheet shows that the firm has $493.82M in Cash & Short Term Investments as of fiscal 2022. There were $2.36M in debt and $44.52M in liabilities at the time. Its Book Value Per Share was $3.06, while its Total Shareholder’s Equity was $469.82M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMVT is Buy with a score of 4.87.
